top of page
smart toothbrush_edited_edited.jpg
toothbrushai COMING 2026.png

Technology & Market Analysis

Add a little bit of body text.png

Look below for our preliminary Market Analysis, Technology Overview, and Financial Projections.

Our Innovation

Our Innovation has the potential to unlock healthcare access for all. Its low cost and seamless integration into our daily lives can redefine screening and diagnostics as we know it, transcending traditional barriers.

​​

Thousands of molecules evaporate from our blood circulation into our lungs and out of our breath. Then when we are brushing it enters the smart toothbrush, where they are detected by a microchip sensor.

​​

Many diseases subtly influence our metabolism even before symptoms manifest, creating unique volatile organic compound (VOC) profiles that serve as biomarkers. ToothbrushAi leverages this phenomenon by interpreting these VOCs, released with every exhalation, during our daily brushing routine. This proactive approach allows for early disease detection, contributing to a more convenient and effective healthcare experience.

​

Our innovative solution possesses the technological capabilities to leverage high data collection potential within its applications, facilitating the accumulation and construction of substantial individual and medical databases over time.

​

ToothbrushAi can pioneer a new era where health knows no bounds. With affordability at its core, it democratizes healthcare, ensuring that every individual, regardless of location or financial status, can benefit from swift and timely diagnosis. Within ToothbrushAi lies the promise of a healthier, more accessible world, where innovation bridges the gaps in healthcare.

​​

The future of medical diagnosis and treatment is on the cusp of a profound transformation, ushered in by the groundbreaking field of airborne biomarker medical device innovation and artificial intelligence. This cutting-edge technology leverages the subtle yet powerful signals present in our breath – volatile organic compounds (VOCs) – to unlock a world of non-invasive, early disease detection, and personalized healthcare.

E-nose technology, artificial intelligence, and machine learning, the cornerstone of this innovation, are rapidly evolving, with the potential to redefine the diagnostic landscape. By harnessing the unique VOC signatures associated with various diseases, e-noses offer a new frontier in precision medicine.

Imagine a future where daily brushing your teeth becomes a proactive health check. By integrating e-nose technology into everyday devices. This convergence promises:

 

  • Early detection: Identify diseases long before symptoms manifest, enabling timely intervention and improved outcomes.

  • Unparalleled accuracy: Diagnosis at a molecular level, surpassing the limitations of traditional tests.

  • Patient-centric care: Non-invasive, comfortable testing that empowers individuals to take charge of their health.

  • Accessibility: Cost-effective solutions with the potential to democratize healthcare access globally.


The synergy of e-noses, artificial intelligence, and machine learning ubiquitous platforms in toothbrushAi heralds a future where healthcare is proactive, personalized, and seamlessly integrated into our daily lives. ToothbrushAi innovation is not just technological advancements; It represents a paradigm shift toward a more empowered and informed healthcare landscape.

Our Innovation
Market Analysis
Financial projections

We are pioneering the future of personalized diagnostics with the development of the world's most convenient airborne biomarker analyzer. Our groundbreaking device, equipped with the world’s smallest, high-resolution CMOS semiconductor-based airborne biomarker imaging sensor chip, is set to revolutionize early disease detection by harnessing the power of airborne biomarkers originating directly from the blood circulation.

​

This cutting-edge technology promises to empower individuals with unprecedented access to real-time health insights, ushering in a new era of proactive and personalized healthcare management. It is fully integrated, cost-effective, and delivers results in real-time from the convenience of the individual home.

​​​​​

At the front end of our medical device lies the airborne biomarker analyzer microchip. Each breath sample that passes over the airborne biomarker microchip produces a unique "digital airborne code" that is loaded with health information. Next sits our proprietary perceptive Ai engine. It applies a complex series of algorithms to precisely interpret the digital biomarker print, identifying disease biomarkers. Results are instantly processed in the clouds, allowing for seamless, real-time integration with nearly any electronic medical record (EMR)

system.​

The Science Behind the Breathtaking Innovation: Our bodies constantly emit a complex array of volatile organic compounds (VOCs), carrying vital information about our internal health. ToothbrushAi's e-nose sensor, seamlessly integrated into the toothbrush, captures and analyzes these VOCs during routine brushing. This data is transmitted to a sophisticated medical health app, where advanced algorithms decipher the VOC profiles, translating them into actionable health insights presented in a user-friendly format.

 

The ToothbrushAi Microchip E-Nose: One of the key technologies of ToothbrushAi lies in its microchip e-Nose sensor with Complementary Metal-Oxide-Semiconductor. This multi-array sensor, equipped with diverse airborne biomarker adsorption films, detects and analyzes VOCs with unprecedented precision. Each unique VOC profile is cataloged in a digital database, allowing for precise identification and discrimination. Unlike conventional gas sensors, ToothbrushAi's e-nose can decipher the complexities of human breath, opening a window into the individual inner health landscape.

​

The membrane, within the sensor element area, is deposited using the printing technology of SIJ Technology, which possesses super inkjet technology capable of forming the world’s smallest droplets capable of single-micron-level fine dispensing.

As a result, toothbrushAi is developing a technology that enables to configure over 100 odor-receptor membranes within a sensor element area of 1 mm x 1 mm.

​​

A CMOS semiconductor type airborne biomarker imaging sensor chip is a type of electronic nose, or e-nose. This means it's designed to detect and analyze different airborne biomarkers. 

​

  • CMOS Semiconductor: This is a very common type of integrated circuit used in many electronic devices. It's known for its low power consumption and high integration density.  

  • Airborne Biomarker Imaging Sensor Chip: This chip is designed specifically to capture and analyze different airborne biomarkers. It contains an array of sensor elements that react to different volatile organic compounds (VOCs) - the chemicals that make up airborne biomarkers and odors.  

  • Sensor Element Area is 1mm x 1mm : This refers to the physical size of each individual sensor on the chip. The smaller the sensor element area, the more sensors can be packed into a chip, leading to a higher resolution image of the odor being analyzed.


ToothbrushAi presents an investment opportunity with the potential to reshape the healthcare landscape:

  • Early Disease Detection: Identify diseases like cancer, diabetes, and heart disease at their earliest stages, significantly improving treatment outcomes and saving lives.

  • Personalized Health Management: Empower individuals with real-time VOC analysis, enabling proactive health management and personalized lifestyle choices for optimal well-being.

  • Remote Patient Monitoring: Facilitate remote monitoring of patient health, enabling healthcare professionals to optimize treatment plans and reduce hospitalizations.

  • Expanding Horizons: Advancements in e-nose technology and VOC identification algorithms promise a future where ToothbrushAi can detect an even wider range of diseases, solidifying its position as an indispensable healthcare tool.

 

The high resolution, combined with the power of AI, and machine learning enables toothbrushAi to identify subtle differences in breath airborne biomarker composition, detecting diseases at very early stages.

toothbrushai technology

Market Analysis

​

ToothbrushAi, stands at the convergence of multiple booming healthcare trends, positioning it for significant market impact. This report analyzes the key markets ToothbrushAi can disrupt, their sizes and trends, and how this innovative technology can reshape healthcare landscapes. This report also shares, at the bottom of this page, two-year sales financial graphs.


Market Convergence:

  • Global Toothbrush Market (US$6.6 billion in 2021): Growing focus on oral health, personalized care, and technological integration presents an opportunity for ToothbrushAi to revolutionize routine brushing with early disease detection capabilities.

  • Medical Diagnostics & Health Management (US$1 trillion+): The aging population, rising chronic diseases, and increasing healthcare costs drive demand for affordable, accessible early diagnosis solutions, perfectly aligning with ToothbrushAi's non-invasive approach.

  • mHealth Apps Market (US$105.9 billion by 2030): With its personalized health insights and seamless smartphone integration, ToothbrushAi taps into the surging demand for mHealth solutions empowering individuals to actively manage their well-being.

  • At-Home Oral Hygiene Market (US$33.7 billion): By elevating oral care beyond plaque removal to early disease detection, ToothbrushAi offers a compelling value proposition in this rapidly growing market.

  • Airborne Biomarker Market (Emerging but Promising): ToothbrushAi's convenient breath analysis method positions it as a potential leader in this emerging market with immense potential for personalized medicine and early diagnosis.

 

Market Impact:

  • Disruptive Technology: ToothbrushAi combines familiar daily routines with advanced healthcare, creating new market segments and expanding existing ones. Its non-invasive, at-home approach democratizes preventive healthcare and empowers individuals to take charge of their health.

  • Market Size Expansion: By making healthcare more accessible and convenient, ToothbrushAi has the potential to significantly grow converging markets. Early detection and personalized healthcare can attract a broader population seeking proactive solutions.

  • Market Segmentation: ToothbrushAi's unique technology creates new consumer-facing segments within medical diagnostics and health management, catering to individuals seeking personalized, convenient healthcare options.

 

Potential Benefits:

  • Early Disease Detection: ToothbrushAi's ability to detect diseases like cancer, diabetes, heart disease, periodontitis, and others at early stages can transform treatment outcomes and improve patient well-being.

  • Personalized Healthcare: Real-time health insights empower individuals to make informed decisions about their health and prevent or manage chronic conditions effectively.

  • Preventive Oral Care: Integrating early disease detection into routine brushing encourages proactive oral hygiene practices, leading to better oral health and potentially reducing healthcare costs.

 

The Opportunity:
ToothbrushAi presents an investment opportunity at the intersection of disruptive technology, growing markets, and experienced leadership. This report outlines the key reasons why partnering with the creator of ToothbrushAi holds the potential for significant returns and a positive impact on the healthcare landscape.

 

Value Proposition:

  • Proven Leadership and Regulatory Expertise: Our seasoned team, led by a founder with a proven track record in obtaining FDA clearance for more challenging medical devices, is uniquely positioned to navigate the complexities of development and regulatory processes. This experience significantly de-risks our project and ensures a streamlined path to market. Additionally, our founder's extensive R&D background in biochemistry, biotechnology and medical devices provides a solid foundation for efficient and innovative product development.

  • High-Growth Start-up: ToothbrushAi leverages novel technology to address unmet needs in the early diagnostics and personalized healthcare markets.

  • Unique Technology: The personal device breath analysis method and system offers the potential for real-time, non-invasive, and early diagnostics surpassing existing standards, revolutionizing healthcare management.

 

Traction and Potential:

  • Filed US & International Provisional Patents: Secured intellectual property protection strengthens the competitive edge and future value.

  • Microchip Sensor Testing: Ongoing testing validates the technology's accuracy and effectiveness at the molecular level.

  • Self-Funded R&D: The bootstrapped approach demonstrates cost-effectiveness and a clear vision for future growth.

 

Market Advantages:

  • Cost Reduction: Seamless at-home diagnostics and health management can significantly reduce healthcare costs by empowering individuals to manage their health proactively.

  • Mass Production Potential: The device's manufacturing makes it accessible to a broad consumer base, maximizing market reach.

  • Targeting High-Value Markets: Focusing on personal care and diagnostics positions ToothbrushAi in rapidly growing and lucrative segments.

 

Future Growth:

  • Clear Vision: The founder's focus on user-centric diagnostics and real-time health management systems aligns with evolving healthcare trends, ensuring lasting relevance.

  • Scalable Technology: The potential for adapting the technology to multiple applications expands future horizons and market opportunities.



COMPETITION: A Competitive Analysis
ToothbrushAi will enters the healthcare arena with a unique value proposition, poised to compete with established players in both the global toothbrush market and the personalized healthcare medical devices market.


Traditional toothbrush giants like Colgate-Palmolive, Procter & Gamble, Unilever, and Johnson & Johnson dominate this market. However, their focus remains primarily on basic oral hygiene with limited technological integration. ToothbrushAi disrupts this landscape by seamlessly integrating advanced healthcare functionalities into a familiar daily routine, offering early disease detection alongside plaque removal.

 

Personalized Healthcare Medical Devices Market (Growing Rapidly):
Players like Abbott Laboratories, Analog Devices, Apple Inc., Bayer AG, Boston Scientific Corporation, GE Healthcare, Koninklijke Philips NV, Medtronic plc, Omron Corporation, and Siemens Healthineers lead this dynamic market. However, many existing solutions are often invasive, expensive, and require clinical settings. ToothbrushAi stands out with its non-invasive, convenient, and at-home approach, empowering individuals to actively participate in their health management.


Competitive Advantages:

  • Unique Value Proposition: Combining routine brushing with early disease detection differentiates ToothbrushAi from traditional toothbrushes and empowers individuals to take charge of their health.

  • Non-invasive and Convenient: Breath analysis eliminates the need for needles or blood draws, making it a more accessible and user-friendly option than many existing health monitoring devices.

  • Personalized Health Insights: Real-time data analysis and actionable insights provided through the accompanying app put individuals at the center of their health journey.

  • Early Disease Detection Potential: ToothbrushAi has the potential to detect various diseases at early stages, improving treatment outcomes and potentially reducing healthcare costs.

  • Growing Market Convergence: ToothbrushAi sits at the intersection of multiple booming healthcare trends, positioning it for significant market impact as these markets continue to grow.


The medical device industry is very competitive; this can lead to price pressure and a need for continuous innovation - despite these challenges, the medical device industry is a large and growing industry with a bright future. To overcome these challenges, our product is based on patented methods and systems and new innovative technologies.


ToothbrushAi, with its unique value proposition, stands poised to carve out a significant market share in the converging worlds of toothbrushes and personalized healthcare. By addressing the challenges, capitalizing on the opportunities, and leveraging strategic partnerships, ToothbrushAi has the potential to revolutionize the way we approach healthcare and empower individuals to take charge of their well-being.

 

Market Challenges
While the market potential is significant, challenges remain:

  • Regulatory approval milestone: The developed FDA strategy by our dedicated medical device expects reports a conservative timeline of 4-6 months. (FDA regulatory strategy available upon request)

  • Consumer education: Raising awareness about the benefits of breath analysis and early disease detection is crucial for market adoption.

  • Data privacy and security: Ensuring robust data protection measures is essential to building trust with consumers.

 

Despite these challenges, the opportunities are vast:

  • Strategic partnerships: Collaboration with established players in both markets can accelerate market penetration and build trust.

  • Data-driven insights: Leveraging the wealth of data collected can lead to further innovation and personalized healthcare solutions. In addition, human health data has immense potential value, potentially worth billions.

  • Global expansion: With its universal appeal, ToothbrushAi has the potential to disrupt healthcare markets worldwide.

​

Home and Professional Markets Size Overview
The ToothbrushAi device presents a significant opportunity to revolutionize personal healthcare by enabling real-time health monitoring and management at home. The device's potential to reduce healthcare costs and improve quality of life makes it accessible to a broad population. The system's ability to diagnose medical conditions, track health progress, and identify potential problems early can significantly enhance the efficiency and affordability of healthcare management. The ToothbrushAi system offers a wide range of features, including integration with electronic health records and telehealth capabilities, further streamlining healthcare delivery. The device's ease of use, security features, and affordability make it a promising solution for improving the quality, efficiency, and cost-effectiveness of healthcare.


Markets Segmentation
The ToothbrushAi device and system offer significant innovation over existing products or services in terms of technology, functionality, or usability. As a candidate for a disruptive medical device and healthcare management system, our product taps into different categories of the global healthcare market including various segments under healthcare medical devices and service types and applications. The figure above provides a basic market size overview of the different healthcare classifications in the industry.
Personal devices are becoming increasingly popular as they offer a way for people to track their health data and improve their fitness levels. These devices can also be used to monitor patients with chronic conditions, such as diabetes and heart disease.


Telehealth is the use of telecommunications technologies to provide healthcare services remotely. This can include video conferencing, phone calls, and secure messaging. ToothbrushAi device and system use telehealth to provide preventive care and diagnose and manage chronic conditions.
The ToothbrushAi device and system artificial intelligence (AI) is being used to continue developing a variety of healthcare applications, such as helping in decision support tools, diagnostic tools, and ever-changing patient monitoring systems. The AI aspect of the ToothbrushAi device and system has the potential to revolutionize healthcare by improving the quality, efficiency, and affordability of care.

 

Key Market Players
Some of the key players in the global toothbrush market are Colgate-Palmolive, Procter & Gamble, Unilever, Johnson & Johnson, and the Oral-B Company.
Some of the key players in the global personalized healthcare medical devices market are Abbott Laboratories, Analog Devices, Apple Inc., Bayer AG, Boston Scientific Corporation, GE Healthcare, Koninklijke Philips NV, Medtronic plc, Omron Corporation andSiemens Healthineers

 

Market Trends
Some of the key trends in the global toothbrush market are increasing focus on oral health, growing demand for personalized oral care products, and increasing use of technology in toothbrushes.


The market for medical devices and healthcare management is growing rapidly, due to several factors, including the aging population, the rise of chronic diseases, the increasing cost of healthcare, and the growing adoption of digital technologies.


The global population is aging, and this is leading to an increase in the number of people with chronic diseases. Chronic diseases, such as heart disease, cancer, and diabetes, are becoming increasingly common. The cost of healthcare is rising, and this is putting pressure on healthcare systems to find ways to reduce costs. Digital technologies, such as artificial intelligence (AI), big data, and the Internet of Things (IoT), are being increasingly adopted in the healthcare industry.


Market Challenges
Some of the key challenges in the global toothbrush market are:

  • High cost of electric toothbrushes

  • Lack of awareness about oral health in developing countries

​

Some of the critical challenges in the global personalized healthcare medical devices market are:

  • High cost of devices

  • Lack of awareness about personalized healthcare medical devices

  • Stringent FDA regulatory requirements

 

Some of the critical challenges in the global medical devices market are:

  • The necessity of adhering to stringent medical device regulations, while potentially posing financial and temporal challenges, is acknowledged. However, the ToothbrushAi device is anticipated to navigate the FDA approval process with relative ease and efficiency.

  • Product recalls: Medical devices can be recalled if they are found to be defective or pose a safety risk. This can be costly and damaging to a company's reputation.

  • Competition: The medical device industry is very competitive, with a large number of companies vying for market share. This can lead to price pressure and a need for continuous innovation.

  • Technology changes: The medical device industry is constantly evolving, with new technologies emerging all the time. This can make it difficult for companies to keep up with the latest trends and stay ahead of the competition.

  • Globalization: The medical device industry is becoming increasingly globalized, with companies competing in markets around the world. This can make it difficult to manage supply chains and ensure quality control.

  • Intellectual property (IP) protection: ToothbrushAi devices are protected by IP, such as patents and trademarks. This can make it difficult for companies to compete if they do not have access to the latest IP.

​

Despite these challenges, the medical device industry is a large and growing industry with a bright future. In general, ToothbrushAi has the potential to significantly impact different markets, both positively and negatively.


The medical device industry is dynamic and ever-changing. To overcome these challenges, ToothbrushAi device and system is based on Nobel innovation, and its primary focus is on patient health and safety. We are also adapting to the changing regulatory landscape and the globalized nature of the industry.

 

Here are some of the ways that our company is overcoming these challenges:

  • Raising capital for investing in research and development to continue developing new ToothbrushAi health management applications. Our company is considering partnering with other companies, such as technology companies and pharmaceutical companies, to create new products and services.

  • Medical device companies are expanding into new markets, such as emerging pets and personal hairbrush markets and others that meet the needs of people as end users at home to increase sales and revenue.

  • Focusing on patient safety: Our primary focus is on people's safety. ToothbrushAi device is non-invasive, safe, and effective.

  • Our company is adopting new technologies, such as artificial intelligence and machine learning, to improve the development, manufacturing, and use of ToothbrushAi device.


Target Market
The strategy is to target approximately 4 billion toothbrush users around the globe in all socioeconomic statuses.

 

In general, our device and health management system would target people of all ages across the globe who are looking to track their health and well-being. ToothbrushAi device is ideal for people who have been diagnosed with different respiratory conditions, any type of cancer, neurodegenerative disorders, bacterial infections, metabolic conditions and many others.

toothbrushai market analysis

​​

Two-Year Sales Financial Projections for ToothbrushAi: The provided financial projections for ToothbrushAi indicate the potential for substantial domestic sales within a two-year timeframe, with estimates ranging from $1.5 billion to $2.5 billion. These projections are based on the anticipated attainment of ambitious, yet achievable, market share targets across various sectors, including medical diagnostics, mHealth applications, home medical equipment, and the traditional toothbrush market.


The analysis underscores the significant market opportunity for ToothbrushAi, driven by its innovative integration of healthcare diagnostics and monitoring capabilities into a daily-use consumer product.

 

Target Market Share and Assumptions:

  • Medical Diagnostics & Health Management Services: 1% market share (USD 818.4 billion market in 2021)

  • mHealth Apps: 3% market share (USD 105.9 billion market by 2030)

  • Home Medical Equipment: 5% market share (USD 34.44 billion market in 2021)

  • Toothbrushes: 9% market share (USD 6.6 billion market in 2021)

 

Key Drivers of Growth:

  • Disruptive Technology: ToothbrushAi's unique combination of familiar routine and advanced healthcare offers early disease detection and personalized insights, attracting health-conscious consumers.

  • Multiple Market Segments: Addressing diverse healthcare needs through medical diagnostics, mHealth apps, and home medical equipment expands market reach and revenue potential.

  • Convenient and Non-invasive: Breath analysis eliminates needles and blood draws, making health monitoring more accessible and user-friendly, appealing to a broader audience.

  • Scalable Technology: The potential to adapt the technology to other applications further increases future market opportunities.

​

Mitigating Strategies:

  • Strategic Partnerships: Collaborating with established players in healthcare can accelerate market penetration and build trust.

  • Compelling Marketing: Implementing a targeted multi-channel marketing strategy focused on education, user testimonials, and partnerships with healthcare providers will drive awareness and adoption.

  • Data Transparency and Security: Implementing ethical data practices and robust security measures will be crucial in building consumer trust.


Market Assumptions

  • Target Population: A conservative estimate suggests that a single-digit percentage of the US population (approximately 332 million) who use toothbrushes will adopt ToothbrushAi.

  • Average Selling Price: The projected average selling price per ToothbrushAi unit is $189 for semiautomated and small-scale manufacturing.

  • Market Share Targets:

    • Medical Diagnostics & Health Management Services: 1%

    • mHealth Apps: 3%

    • Home Medical Equipment: 5%

    • Toothbrush Market: 9%


Sales Projections
The following two tables and three line charts at the bottom of this page illustrate the projected year one and year two of sales figures for ToothbrushAi:


Year Units Sold Revenue - See table below!
Revenue Breakdown by Market -See table below!

Medical Diagnostics & Health Management Services mHealth Apps Home Medical Equipment Toothbrush Market Total See table below!

Key Insights

  • ToothbrushAi demonstrates strong sales potential, with projected domestic revenue reaching $668.6 million in 2026 and $1.34 billion in 2027.

  • The traditional toothbrush market is anticipated to be the primary revenue driver, followed by mHealth apps and home medical equipment.

  • These projections are based on conservative market share estimates, indicating potential for even higher revenue if ToothbrushAi captures a larger market share in these expanding sectors.


Important Notes
• These projections are based on current market analysis and assumptions, and actual results may vary.
• The success of ToothbrushAi is contingent upon several factors, including market acceptance, execution of developed regulatory strategy, competitive landscape, and the effectiveness of marketing and sales strategies.
• A comprehensive financial model should be developed to incorporate costs, expenses, and profitability analysis alongside these revenue projections.

 

table2.jpeg
table1_edited.jpg
Picture1_edited.jpg
Picture2_edited.jpg
Picture3_edited.jpg
toothbrushAi market size luci diagram.png

Conclusion

ToothbrushAi system uses modern medical technology to help people live healthier and longer lives. ToothbrushAi device and system is a non-habit-changing product that offers several benefits over traditional toothbrushes and personalized healthcare management systems so people effortlessly can stay ahead of any health issues in a seamless, low-cost cost, and efficient. By strategically targeting various healthcare and consumer markets, it has the potential to disrupt the healthcare industry. This preliminary report above serves as a foundation for financial planning and can be further refined through additional market research and analysis

toothbrushai Financial Projection
Financial Projections

Stay Connected

Thanks for submitting!

Join the early diagnosis revolution

* Products are currently in development and are not approved by the FDA for sale or distribution.

Please stay tuned for updates.

​

THIS WEBSITE MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY.  THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT.  WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS.  INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE.  THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

​

US & INTERNATIONAL PATENTS PENDING

​

toothbrushAi(13).png

©2024 by Goodness Management, LLC

3035 E Commercial Blvd Fort Lauderdale 33308

bottom of page